TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30379210

Group type: COMPARATOR
Intervention: C1 (1 pressing)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CM3 (3 pressings + mechanical cycling)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CM2 (2 pressings + mechanical cycling)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: C3 (3 pressings)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CM1 (1 pressing + mechanical cycling)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: C2 (2 pressings)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study: 26922019

Group type: EXPERIMENTAL
Intervention: Lung protective ventilation (VT of 6 mL/kg + RMs + PEEP: 5 cmH(2)O (PBW) and RR of 12‐18 /min)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lung protective ventilation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (VT of 10 mL/kg (PBW) and RR of 10‐12 /min)
Number of subjects: 60
Study: 24346821

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 1000 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) 400 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 22433024

Group type: EXPERIMENTAL
Intervention: Telephone interview
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reminder telephone call
Number of subjects: 0
Study: 20642474

Group type: EXPERIMENTAL
Intervention: Rubber dam
Number of subjects: 232

Group type: COMPARATOR
Intervention: Cotton rolls
Number of subjects: 232
Study: 17923633

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CE) for symptomatic patients
Number of subjects: 3283

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CE) for asymptomatic patients
Number of subjects: 3283
Study: 14975052

Group type: EXPERIMENTAL
Intervention: T‐piece mode (4 l/min oxygen via a T‐piece for 2 hours)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pressure support mode (FiO2 </= 0.4, PS </= 10 cmH2O, and positive end expiratory pressure </= 5 cmH2O for 2 hours)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous positive airway pressure mode (FiO2 </= 0.4 and CPAP 5 </= cmH2O for 2 hours)
Number of subjects: 60
Study: 11353931

Group type: EXPERIMENTAL
Intervention: Thrombolysis with tPA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Thrombolysis with SK
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 9398955

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 20
Study: 8214998

Group type: EXPERIMENTAL
Intervention: Weight-based heparin nomogram (starting dose, 80 units/kg body weight bolus, 18 units/kg per hour infusion)
Number of subjects: 115
Study: 3812340

Group type: EXPERIMENTAL
Intervention: Diet A (high-protein and low-fat diet)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diet B (low-protein and high-fat diet)
Number of subjects: 12
Study: 31190459

Group type: EXPERIMENTAL
Intervention: Teach-back heart failure self-management intervention plus usual care
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 140
Study: 30142603

Group type: EXPERIMENTAL
Intervention: 15 accelerated high-frequency (HF)-rTMS sessions at the right dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (abstainers)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Baseline GMV
Number of subjects: 22
Study: 26818881

Group type: COMPARATOR
Intervention: sham
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: right anodal (a-TDCS)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: left cathodal (c-TDCS)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: double source (ds)-TDCS
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: classical bilateral stimulation (bi-TDCS)
Number of subjects: 50
Study: 24210549

Group type: EXPERIMENTAL
Intervention: Apparent treatment-resistant hypertension
Number of subjects: 10001
Study: 22440192

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 8 mg and amlodipine besilate 5 mg (CC/AML 8/5 mg)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Candesartan cilexetil 8 mg (CC 8 mg)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Amlodipine besilate 5 mg (AML 5 mg)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 444
Study: 20632489

Group type: COMPARATOR
Intervention: Routine methods and topical oxygen therapy (Group B)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Routine methods and bFGF therapy (Group C)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Routine methods and bFGF/topical oxygen therapy (Group D)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Routine treatment (Group A)
Number of subjects: 85
Study: 17717526

Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg once daily (q.d.)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study: 16297757

Group type: EXPERIMENTAL
Intervention: Midazolam (0.1 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Butorphanol (0.02 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no premedication)
Number of subjects: 30
Study: 11905429

Group type: EXPERIMENTAL
Intervention: Intravenous oxytocin (10 units)
Number of subjects: 991

Group type: COMPARATOR
Intervention: Intramuscular syntometrine (1 ml)
Number of subjects: 991
Study: 10707131

Group type: EXPERIMENTAL
Intervention: 0.25 ml of Mydricaine No. 1
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no Mydricaine No. 1)
Number of subjects: 49
Study: 8944370

Group type: EXPERIMENTAL
Intervention: Mesalazine 500 mg thrice daily for 7 days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Olsalazine 500 mg twice daily for 7 days
Number of subjects: 15
Study: 2036478

Group type: EXPERIMENTAL
Intervention: Stimulus intensity of 70 dB SL
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Stimulus intensity of 70 dB
Number of subjects: 6
Study: 7082112

Group type: EXPERIMENTAL
Intervention: Two weeks of hospitalization
Number of subjects: 138

Group type: COMPARATOR
Intervention: Three weeks of hospitalization
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Both groups (two weeks and three weeks of hospitalization)
Number of subjects: 138
Study: 31961224

Group type: EXPERIMENTAL
Intervention: Bevacizumab (2.5 mg) - three intravitreal injections at monthly intervals
Number of subjects: 30

Group type: COMPARATOR
Intervention: Triamcinolone (8 mg) - single injection followed by two sham interventions at monthly intervals
Number of subjects: 30
Study: 31524552

Group type: EXPERIMENTAL
Intervention: Microdecision intervention for staff members including systematic listening and offering involvement
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Microdecision intervention
Number of subjects: 685
Study: 28934604

Group type: EXPERIMENTAL
Intervention: Highest quartile of Lp-PLA2 mass
Number of subjects: 3401

Group type: EXPERIMENTAL
Intervention: Highest quartile of Lp-PLA2 mass with higher LDL-C
Number of subjects: 3401
Study: 24482284

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control (Conventional ventilation)
Number of subjects: 170
Study: 23986081

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 22397239

Group type: EXPERIMENTAL
Intervention: Ramipril (N = 23)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Valsartan (N = 22)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Combination of ramipril and valsartan (N = 26)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Combination therapy (ramipril + valsartan)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Monotherapy (ramipril or valsartan)
Number of subjects: 71
Study: 18583434

Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 17509426

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (twice per day dosing regimen: one dose before and three doses after contrast media exposure)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (twice per day dosing regimen: one dose before and three doses after contrast media exposure)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 14715839

Group type: EXPERIMENTAL
Intervention: 3 mg melatonin daily for 4 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 3 mg melatonin daily for 4 weeks (second study)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Melatonin in the first study and placebo in the second
Number of subjects: 14
Study: 11180024

Group type: EXPERIMENTAL
Intervention: Ketoconazole 200 mg once daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ketoconazole 400 mg once daily
Number of subjects: 12
Study: 9368234

Group type: EXPERIMENTAL
Intervention: intensive oral + i.v. magnesium supplementation
Number of subjects: 11
Study: 1609935

Group type: EXPERIMENTAL
Intervention: Bolus plus infusion (4 ml incremental bolus with 15 minute lockout, plus a 4 ml per hour infusion of 0.125% bupivacaine plus fentanyl 3 mcg per ml)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Bolus only (4 ml incremental bolus with 15 minute lockout of 0.125% bupivacaine plus fentanyl 3 mcg per ml)
Number of subjects: 52
Study: 4012373

Group type: EXPERIMENTAL
Intervention: Exercise groups
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nonexercising women
Number of subjects: 50
Study: 3594511

Group type: EXPERIMENTAL
Intervention: Clopamide monotherapy
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Pindolol monotherapy
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Combined pindolol-clopamide therapy
Number of subjects: 49
Study: 27139595

Group type: EXPERIMENTAL
Intervention: Psychotherapy plus gratitude writing
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Psychotherapy plus expressive writing
Number of subjects: 293

Group type: COMPARATOR
Intervention: Psychotherapy only (control)
Number of subjects: 293
Study: 28579062

Group type: EXPERIMENTAL
Intervention: Ultra-widefield fluorescein angiography
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NPA and ISI measurements
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NPA and ISI in midperiphery
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Global NPA and ISI
Number of subjects: 40
Study: 26043562

Group type: EXPERIMENTAL
Intervention: Wuling Capsule (0.33 g/capsule, 3 times per day) + Pinaverium Bromide (50 mg/tablet, 3 times per day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Pinaverium Bromide (50 mg/tablet, 3 times per day)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Wuling Capsule + Pinaverium Bromide
Number of subjects: 64

Group type: COMPARATOR
Intervention: Pinaverium Bromide
Number of subjects: 64
Study: 23829154

Group type: EXPERIMENTAL
Intervention: Caffeine gum (100 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 20070920

Group type: EXPERIMENTAL
Intervention: Interactive activities designed around Piagetian concrete operational schemata
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Mathematics lessons in both Year 1 and Year 2 based on theories from Piaget and Vygotsky
Number of subjects: 275
Study: 18249334

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 52
Study: 16341026

Group type: EXPERIMENTAL
Intervention: Hood nebulization
Number of subjects: 10

Group type: COMPARATOR
Intervention: Mask nebulization
Number of subjects: 10
Study: 14623808

Group type: EXPERIMENTAL
Intervention: Adenosine (0.125 mg/min)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Adenosine (0.5 mg/min)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dipyridamole (loading dose, 0.142 mg/kg per min for 5 minutes followed by 0.004 mg/kg per min)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 7
Study: 10632647

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg o.d. for the first 6 days (PAAz group; n=55)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Clarithromycin 500 mg b.d. for the first 7 days (PAC group; n=55)
Number of subjects: 110
Study: 9197294

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 15
Study: 1606114

Group type: EXPERIMENTAL
Intervention: Two catheters tied together introduced transcervically into the same amniotic fluid pocket
Number of subjects: 20

Group type: COMPARATOR
Intervention: Two catheters introduced in different directions into different pockets of amniotic fluid
Number of subjects: 20
Study: 3987798

Group type: EXPERIMENTAL
Intervention: Intravenous administration of cefuroxime (250 mg) in patients with peritonitis
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Intraperitoneal administration of cefuroxime (250 mg) in patients with peritonitis
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intravenous administration of cefuroxime (250 mg) in uninfected patients
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intraperitoneal administration of cefuroxime (250 mg) in uninfected patients
Number of subjects: 19
Study: 31560945

Group type: EXPERIMENTAL
Intervention: tDCS (10 sessions at 2 mA to the right and left DLPFC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham tDCS (10 sessions)
Number of subjects: 40
Study: 29330176

Group type: EXPERIMENTAL
Intervention: Guided physical exercise and dietary therapy programme (PED‐t)
Number of subjects: 10
Study: 25662447

Group type: EXPERIMENTAL
Intervention: On-pump CABG
Number of subjects: 120

Group type: COMPARATOR
Intervention: Off-pump CABG
Number of subjects: 120
Study: 25377395

Group type: EXPERIMENTAL
Intervention: Morphine and 0.15 mg/kg ketamine (group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Morphine and 0.3 mg/kg ketamine (group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Morphine and normal saline placebo (standard care group)
Number of subjects: 60
Study: 23718080

Group type: EXPERIMENTAL
Intervention: 2% procaine solution administered via electrophoresis and mesotherapy
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo administered via galvanization and mesotherapy
Number of subjects: 95
Study: 20964768

Group type: COMPARATOR
Intervention: Ultrasound-guided transversus abdominis plane (TAP) block
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided ilioinguinal block
Number of subjects: 41
Study: 18226669

Group type: EXPERIMENTAL
Intervention: Transdermal contraceptive patch
Number of subjects: 104

Group type: COMPARATOR
Intervention: Monophasic combination oral contraceptive (COC)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Triphasic COC
Number of subjects: 104
Study: 16620305

Group type: EXPERIMENTAL
Intervention: Beraprost sodium (120 microg/day) for 4 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 25
Study: 12729137

Group type: EXPERIMENTAL
Intervention: Nonlatex condom
Number of subjects: 830

Group type: COMPARATOR
Intervention: Latex condom
Number of subjects: 830
Study: 11103375

Group type: EXPERIMENTAL
Intervention: Telephone counseling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In-person counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 0
Study: 9180855

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) 30 mg/day for 5 years
Number of subjects: 494

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 494
Study: 1286499

Group type: EXPERIMENTAL
Intervention: Flumazenil (0.89 mg IV, range: 0.4 mg to 1 mg)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 184
Study: 3812947

Group type: EXPERIMENTAL
Intervention: Intramuscular nalbuphine 20 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intramuscular pethidine 100 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Infants of mothers given nalbuphine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Infants of mothers given pethidine
Number of subjects: 80
Study: 28950158

Group type: EXPERIMENTAL
Intervention: Aerobic gymnastic exercise (15 minutes per session, at least three times a week for three months)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Aerobic gymnastic exercise
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no aerobic gymnastic exercise)
Number of subjects: 140
Study: 26446253

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg nightly
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 25703411

Group type: EXPERIMENTAL
Intervention: NPWT with sNAG (poly-N-acetyl glucosamine nanofibers)
Number of subjects: 20

Group type: COMPARATOR
Intervention: NPWT alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: NPWT with sNAG in patients treated with antiplatelet drugs
Number of subjects: 20
Study: 23735352

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (600 mg administered intravenously twice)
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (500 mg administered intravenously twice)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 520
Study: 20663805

Group type: EXPERIMENTAL
Intervention: Agomelatine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18283083

Group type: EXPERIMENTAL
Intervention: Better informing patients of the uses of records for medical research purposes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Informed consent procedures that explain the nature of the research and the uses of the data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of identifiers, such as social security numbers for central follow-up
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Legislative changes to reduce restrictions on data use
Number of subjects: 0
Study: 16174205

Group type: EXPERIMENTAL
Intervention: CBT group supervision
Number of subjects: 9

Group type: COMPARATOR
Intervention: Comparison group of psychiatric registrars
Number of subjects: 9
Study: 12854928

Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 238

Group type: COMPARATOR
Intervention: Spinal anesthesia
Number of subjects: 238

Group type: COMPARATOR
Intervention: General anesthesia, Spinal anesthesia, Combined spinal-epidural
Number of subjects: 238
Study: 11021273

Group type: EXPERIMENTAL
Intervention: Internal mammary artery (IMA) graft
Number of subjects: 137

Group type: COMPARATOR
Intervention: Vein graft surgery
Number of subjects: 137
Study: 8712143

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 to 10 mg every morning)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Diltiazem-sustained release (90 to 180 mg twice daily)
Number of subjects: 30
Study: 1940058

Group type: COMPARATOR
Intervention: AZT 0.5 g/day p.o.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: AZT 0.5 g/day p.o. plus IVIG 0.4 g/kg for three consecutive days, followed by 0.6 g/kg every fourth week
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: AZT 0.5 g/day p.o. and IVIG
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: AZT 0.5 g/day p.o. plus IVIG
Number of subjects: 30
Study: 7036400

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg sublingually
Number of subjects: 8

Group type: COMPARATOR
Intervention: Matched placebo capsules
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 8
Study: 31683226

Group type: EXPERIMENTAL
Intervention: Structured and individualised education program delivered by a primary care nurse, consisting of six face-to-face sessions of 30 minutes each, with follow-ups after 12 and 24 months.
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Structured and individualised education program delivered by a primary care nurse.
Number of subjects: 236

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 236
Study: 31479137

Group type: EXPERIMENTAL
Intervention: N95 respirators
Number of subjects: 2862

Group type: COMPARATOR
Intervention: Medical masks
Number of subjects: 2862
Study: 28526315

Group type: EXPERIMENTAL
Intervention: VAP education (intensive educational program)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no VAP education)
Number of subjects: 102
Study: 25361552

Group type: EXPERIMENTAL
Intervention: Parental MVP
Number of subjects: 3679

Group type: EXPERIMENTAL
Intervention: Parental NDMs
Number of subjects: 3679
Study: 23831502

Group type: EXPERIMENTAL
Intervention: Experimental group with task cards integrating pictures and written instructions close together
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group with written instructions placed under the picture on the task cards
Number of subjects: 111
Study: 21733742

Group type: EXPERIMENTAL
Intervention: Groningen Ultra Low Resistance (GULR)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Provox2
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study: 19398814

Group type: EXPERIMENTAL
Intervention: Electrical impedance spectroscopy method applied to effective electrical properties of cancellous bone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sensitivity analysis with normally distributed random noise added to data
Number of subjects: 0
Study: 16393881

Group type: EXPERIMENTAL
Intervention: Longer CAG repeats in second polymorphic KCNN3 region
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (46 individuals)
Number of subjects: 101
Study: 15296683

Group type: EXPERIMENTAL
Intervention: Tailored lifestyle self-management intervention including follow-up telephone calls
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 100
Study: 11506106

Group type: EXPERIMENTAL
Intervention: Desflurane (2, 4, and 6% end tidal; n = 10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sevoflurane (1, 2, and 3% end tidal; n = 10)
Number of subjects: 20
Study: 9205768

Group type: EXPERIMENTAL
Intervention: Ebrotidine 400 mg and ranitidine 300 mg combined with amoxicillin 750 mg and metronidazole 500 mg for 14 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group receiving the same treatment
Number of subjects: 30